Published in Oncogene on August 30, 2010
Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov (2011) 3.54
Small-molecule-induced DNA damage identifies alternative DNA structures in human genes. Nat Chem Biol (2012) 2.41
Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities. J Exp Clin Cancer Res (2014) 1.39
PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res (2011) 1.23
Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol (2012) 1.06
One identity or more for telomeres? Front Oncol (2013) 0.91
Experimental approaches to identify cellular G-quadruplex structures and functions. Methods (2012) 0.91
G-quadruplexes significantly stimulate Pif1 helicase-catalyzed duplex DNA unwinding. J Biol Chem (2015) 0.91
A TRF1-controlled common fragile site containing interstitial telomeric sequences. Chromosoma (2012) 0.89
Re-evaluating PARP1 inhibitor in cancer. Nat Biotechnol (2011) 0.86
On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts. J Exp Clin Cancer Res (2013) 0.83
Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance. Nucleic Acids Res (2015) 0.78
A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compounds. Nucleic Acids Res (2015) 0.78
DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential. Nat Rev Mol Cell Biol (2017) 0.78
Mechanism of the antiproliferative activity of some naphthalene diimide G-quadruplex ligands. Mol Pharmacol (2012) 0.76
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2. Cell Death Differ (2017) 0.75
Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA. Proc Natl Acad Sci U S A (2016) 0.75
Bis-indole derivatives with antitumor activity turn out to be specific ligands of human telomeric G-quadruplex. Front Chem (2014) 0.75
A G-quadruplex structure at the 5' end of the H19 coding region regulates H19 transcription. Sci Rep (2017) 0.75
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
Interaction ruling animal collective behavior depends on topological rather than metric distance: evidence from a field study. Proc Natl Acad Sci U S A (2008) 9.37
A protein-counting mechanism for telomere length regulation in yeast. Science (1997) 4.79
A family of dispersed repetitive extragenic palindromic DNA sequences in E. coli. EMBO J (1984) 4.07
SIR3 and SIR4 proteins are required for the positioning and integrity of yeast telomeres. Cell (1993) 3.77
Telomeric localization of TRF2, a novel human telobox protein. Nat Genet (1997) 3.23
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol (2001) 2.93
Evidence for silencing compartments within the yeast nucleus: a role for telomere proximity and Sir protein concentration in silencer-mediated repression. Genes Dev (1996) 2.85
Prevention of anterior cruciate ligament injuries in soccer. A prospective controlled study of proprioceptive training. Knee Surg Sports Traumatol Arthrosc (1996) 2.53
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Cell cycle restriction of telomere elongation. Curr Biol (2000) 2.46
Cohabitation of insulators and silencing elements in yeast subtelomeric regions. EMBO J (1999) 2.45
Sequence of the malK gene in E.coli K12. Nucleic Acids Res (1982) 2.43
Interaction between Set1p and checkpoint protein Mec3p in DNA repair and telomere functions. Nat Genet (1999) 2.43
Progressive cis-inhibition of telomerase upon telomere elongation. EMBO J (1999) 2.37
First measurement of kaonic helium-3 X-rays. Phys Lett B (2011) 2.37
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571. J Natl Cancer Inst (2000) 2.06
Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by Rap 1 protein. Genes Dev (1996) 2.02
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. Eur J Cancer (2001) 2.02
The telobox, a Myb-related telomeric DNA binding motif found in proteins from yeast, plants and human. Nucleic Acids Res (1996) 1.98
Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol (1998) 1.83
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet (1991) 1.82
Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis (2004) 1.82
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. J Natl Cancer Inst (1996) 1.74
A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol (1991) 1.74
Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett (1992) 1.62
Molecular heterogeneity of beta thalassaemia in the Italian population. Br J Haematol (1984) 1.57
Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Int Immunopharmacol (2005) 1.55
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells. Eur Respir J (2011) 1.53
L-Asparagine depletion in plasma and cerebro-spinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase. Ann Oncol (1996) 1.52
Cooperation at a distance between silencers and proto-silencers at the yeast HML locus. EMBO J (1996) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45
Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill (2011) 1.44
Nuclear envelope associated protein that binds telomeric DNAs. Mol Reprod Dev (2000) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin. Ann Oncol (1999) 1.42
Unsteady flow through in-vitro models of the glottis. J Acoust Soc Am (2003) 1.41
Extensive homology between membrane-associated components of histidine and maltose transport systems of Salmonella typhimurium and Escherichia coli. J Biol Chem (1982) 1.39
Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int (1995) 1.39
Hemoglobinometry in human blood. Methods Enzymol (1981) 1.39
Hepatitis G virus infection in the elderly. Ital J Gastroenterol Hepatol (1998) 1.37
Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res (1991) 1.34
The set1Delta mutation unveils a novel signaling pathway relayed by the Rad53-dependent hyperphosphorylation of replication protein A that leads to transcriptional activation of repair genes. Genes Dev (2001) 1.34
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. Proc Natl Acad Sci U S A (2000) 1.34
In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles. Br J Cancer (2002) 1.34
An activation-independent role of transcription factors in insulator function. EMBO Rep (2001) 1.32
Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways. Int J Cancer (2001) 1.31
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol (2009) 1.31
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
Dark matter results from 225 live days of XENON100 data. Phys Rev Lett (2012) 1.31
Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res (1991) 1.31
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am J Pathol (2001) 1.29
Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res (1986) 1.29
Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res (1989) 1.28
Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. Int J Cancer (1996) 1.27
Measurements of the strong-interaction widths of the kaonic (3)He and (4)He 2p levels. Phys Lett B (2012) 1.27
Palindromic units from E. coli as binding sites for a chromoid-associated protein. FEBS Lett (1986) 1.27
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res (1987) 1.26
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology (2000) 1.25
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure. Ann Oncol (2000) 1.23
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) (1987) 1.23
Structural and functional diversity among bacterial interspersed mosaic elements (BIMEs). Mol Microbiol (1994) 1.22
bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer (2000) 1.22
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res (1997) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. Clin Cancer Res (1998) 1.21
c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Cancer Res (1998) 1.19
Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer (2007) 1.18
Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci (1999) 1.16
Ku-deficient yeast strains exhibit alternative states of silencing competence. EMBO Rep (2001) 1.16
Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clin Cancer Res (1999) 1.15
Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J (2000) 1.15
Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1992) 1.14
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res (2001) 1.13
Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. II. Bleomycin and hydroxyurea. J Natl Cancer Inst (1974) 1.13
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. Ann Oncol (1997) 1.12
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study. Neurol Sci (2011) 1.11
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line. Cell Prolif (2011) 1.11
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Exp Cell Res (1998) 1.11
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes. Exp Cell Res (1994) 1.11
Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. Cancer Res (1986) 1.11
Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2. Int J Cancer (1999) 1.11
Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Res (1994) 1.10
Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res (1988) 1.10
Proteins that bind to double-stranded regions of telomeric DNA. Trends Cell Biol (1997) 1.10
Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol (1993) 1.10
Requirement of phospholipase C-catalyzed hydrolysis of phosphatidylcholine for maturation of Xenopus laevis oocytes in response to insulin and ras p21. J Biol Chem (1991) 1.09
Rap1p and telomere length regulation in yeast. Ciba Found Symp (1997) 1.09
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Limits on neutrino emission from gamma-ray bursts with the 40 string IceCube detector. Phys Rev Lett (2011) 1.08